These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Voriconazole at Saint Louis Hospital (Paris): Analysis of two-years of compassionate use]. Papy E; Carde A; Ribaud P; Faure P; Touratier S Presse Med; 2006 Feb; 35(2 Pt 1):251-2. PubMed ID: 16493359 [No Abstract] [Full Text] [Related]
10. Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients. Kim SH; Yim DS; Choi SM; Kwon JC; Han S; Lee DG; Park C; Kwon EY; Park SH; Choi JH; Yoo JH Int J Infect Dis; 2011 Nov; 15(11):e753-8. PubMed ID: 21831685 [TBL] [Abstract][Full Text] [Related]
11. [Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection]. Sun HL; Zhou X; Shen YF Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):558-9. PubMed ID: 22338183 [No Abstract] [Full Text] [Related]
12. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis. Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338 [TBL] [Abstract][Full Text] [Related]
13. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study. Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283 [TBL] [Abstract][Full Text] [Related]
14. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed. Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210 [TBL] [Abstract][Full Text] [Related]
15. A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections. Yilmaz D; Balkan C; Ay Y; Akin M; Karapinar B; Kavakli K Mycoses; 2011 May; 54(3):234-42. PubMed ID: 19906090 [TBL] [Abstract][Full Text] [Related]
17. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720 [TBL] [Abstract][Full Text] [Related]